Skip to main content

Table 8 LS mean of changes from baseline in FACT-B SWB score with 95 % CIs (final analysis set)

From: Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study

  

Final analysis set (N = 486)

  

LS mean

95 % CI

P value

Follow-up

6 months

0.85

0.07–1.63

–

 

12 months

1.02

0.23–1.80

–

 

18 months

0.13

−0.69 to 0.95

–

 

24 months

0.22

−0.62 to 1.07

–

 

6–12 months

−0.16

−0.63 to 0.30

.4849

 

6–18 months

0.72

0.21–1.23

.0057

 

6– 24 months

0.63

0.05–1.20

.0323

 

12–18 months

0.89

0.49–1.28

<.0001

 

12–24 months

0.79

0.27–1.31

.0029

 

18–24 months

−0.09

−0.51 to 0.32

.6622

Prior chemotherapies

Yes

1.75

0.90–2.61

-

 

No

−0.64

−1.49 to 0.21

-

 

Yes–No

2.40

1.60-3.19

<.0001

Age group

>60 years

1.30

0.39–2.22

–

 

≤60 years

−0.19

−0.99 to 0.60

–

 

>60 to ≤60 years

1.50

0.68–2.32

.0004

Mastectomy

Yes

0.72

0.21–1.24

–

 

No

0.39

−1.02 to 1.79

–

 

Yes–No

0.33

−1.16 to 1.83

.6596

Axillary lymph-node dissection

Yes

0.06

−0.78 to 0.90

–

 

No

1.05

0.10–2.00

–

 

Yes–No

−0.99

−1.97 to −0.01

.0482